Eric J. Small, MD
University of California, San Francisco
7
0
6
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+17 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Patrick J. Loehrer, MD
Indiana University
Shared therapeutic areas:
Worked with same sponsors:
Kim A. Margolin, MD
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Robert J. Motzer, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Daniel P. Petrylak, MD
Herbert Irving Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
George Wilding, MD
University of Wisconsin, Madison
Shared therapeutic areas:
Worked with same sponsors:
Maha Hadi A. Hussain, MD
University of Michigan Rogel Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Patrick A. Burch, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Bryan J. Donnelly, MD, FRCSC, MSC
Tom Baker Cancer Centre - Calgary
Shared therapeutic areas:
Worked with same sponsors:
Atif Akdas, MD
Marmara University Hospital
Shared therapeutic areas:
Worked with same sponsors:
Kevin Volpp, MD, PhD
University of Pennsylvania
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer
Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer
S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
APC8015 and Bevacizumab in Treating Patients With Prostate Cancer
Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer
All 7 trials loaded